Oncternal Therapeutics, Inc. Common Stock

ONCT

Market cap $1.56M

Delisted

ONCT was delisted on the 2nd of December, 2024.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	AC 1 Armistice Capital New York	$2.24M	+$146K	+2,972	+5%
2	NCM 2 Nantahala Capital Management New Canaan, Connecticut	$2.04M	+$2.94M	+60,037	New
3	3 Creative Planning Overland Park, Kansas	$829K	–	–	–
4	4 Vanguard Group Malvern, Pennsylvania	$473K	-$15.2K	-310	-2%
5	OM 5 Opaleye Management Boston, Massachusetts	$331K	+$477K	+9,727	New
6	DY 6 Dowling & Yahnke San Diego, California	$256K	–	–	–
7	7 Renaissance Technologies New York	$251K	+$195K	+3,982	+117%
8	UCFA 8 United Capital Financial Advisors Irving, Texas	$144K	–	–	–
9	IC 9 IEQ Capital Foster City, California	$123K	–	–	–
10	AAM 10 Aureus Asset Management Boston, Massachusetts	$119K	–	–	–
11	11 BlackRock New York	$110K	-$1.67K	-34	-1%
12	12 Millennium Management New York	$60K	-$66.5K	-1,357	-43%
13	13 Morgan Stanley New York	$46K	+$13.5K	+275	+26%
14	14 Geode Capital Management Boston, Massachusetts	$32K	–	–	–
15	15 State Street Boston, Massachusetts	$30K	-$8.58K	-175	-16%
16	16 Northern Trust Chicago, Illinois	$26K	+$3.19K	+65	+9%
17	CCM 17 Cohen Capital Management Corte Madera, California	$22K	–	–	–
18	18 Bank of America Charlotte, North Carolina	$10K	+$49	+1	+0.3%
19	NSIM 19 North Star Investment Management Chicago, Illinois	$7K	–	–	–
20	20 UBS Group Zurich, Switzerland	$7K	+$9.46K	+193	New
21	TRCT 21 Tower Research Capital (TRC) New York	$2K	+$3.53K	+72	New
22	MAM 22 Meeder Asset Management Dublin, Ohio	–	-$6K	-107	Closed